ALX Oncology Holdings Q3 Adj. EPS $(0.13) Beats $(0.14) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 63.89 percent increase over losses of $(0.36) per share
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 63.89 percent increase over losses of $(0.36) per share from the same period last year.
